Kura Oncology Inc (NASDAQ: KURA) is -25.14% lower on its value in year-to-date trading and has touched a low of $6.27 and a high of $23.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KURA stock was last observed hovering at around $6.38 in the last trading session, with the day’s gains setting it 0.14%.
Currently trading at $6.52, the stock is -10.14% and -15.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.23 million and changing 2.19% at the moment leaves the stock -55.10% off its SMA200. KURA registered -70.12% loss for a year compared to 6-month loss of -66.63%. The firm has a 50-day simple moving average (SMA 50) of $7.7539 and a 200-day simple moving average (SMA200) of $14.52005.
The stock witnessed a -11.05% gain in the last 1 month and extending the period to 3 months gives it a -23.38%, and is -8.68% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.97% over the week and 5.94% over the month.
Kura Oncology Inc (KURA) has around 192 employees, a market worth around $526.53M and $53.88M in sales. Profit margin for the company is -322.89%. Distance from 52-week low is 3.99% and -72.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-40.87%).
with sales reaching $39.08M over the same period.The EPS is expected to grow by 10.35% this year, but quarterly earnings will post 148.68% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
257.0 institutions hold shares in Kura Oncology Inc (KURA), with institutional investors hold 103.36% of the company’s shares. The shares outstanding are 78.23M, and float is at 75.15M with Short Float at 12.01%. Institutions hold 102.17% of the Float.
The top institutional shareholder in the company is SUVRETTA CAPITAL MANAGEMENT, LLC with over 7.07 million shares valued at $145.56 million. The investor’s holdings represent 8.1602 of the KURA Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 6.97 million shares valued at $143.43 million to account for 8.0404 of the shares outstanding. The other top investors are ECOR1 CAPITAL, LLC which holds 5.81 million shares representing 6.7027 and valued at over $119.56 million, while DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds 6.2464 of the shares totaling 5.41 million with a market value of $111.42 million.
Kura Oncology Inc (KURA) Insider Activity
The most recent transaction is an insider sale by Hasnain Faheem, the company’s Director. SEC filings show that Hasnain Faheem sold 22,682 shares of the company’s common stock on Mar 21 ’25 at a price of $8.00 per share for a total of $0.18 million. Following the sale, the insider now owns 23983.0 shares.
Still, SEC filings show that on Jan 28 ’25, DOYLE THOMAS JAMES (SVP, Finance & Accounting) disposed off 4,949 shares at an average price of $7.87 for $38958.0. The insider now directly holds 88,193 shares of Kura Oncology Inc (KURA).
